Neurophet AQUA
JSON twin: https://www.healthaidb.com/software/neurophet-aqua.json
Company Name
Neurophet
Product URL
https://neurophet.com/Products/AQUA
Company URL
https://neurophet.com
Categories
Summary
Neurophet AQUA is an AI-powered software that analyzes brain MRI scans to assist in diagnosing and monitoring neurodegenerative diseases, including Alzheimer's and multiple sclerosis.
Description
Neurophet AQUA utilizes artificial intelligence to analyze brain MRI scans, providing rapid segmentation and analysis of brain images within five minutes. It quantifies brain volume and white matter hyperintensities (WMH), aiding in the diagnosis and prognosis assessment of neurodegenerative diseases such as Alzheimer's and multiple sclerosis. The software offers automated brain segmentation, atrophy pattern analysis by brain region, brain atrophy percentile analysis, and automated inter-operation with PACS. It is FDA-cleared, CE-marked, and approved in multiple countries, including Korea, Japan, and Singapore.
Api Available
unknown
Certifications
- FDA 510(k)
- CE (MDD)
- MFDS (Korea)
- MHLW (Japan)
- HAS (Singapore)
- TFDA (Thailand)
Company Founding
2016
Company Offices
Compliance
- US FDA 510(k) cleared
- CE (MDD)
- MFDS (Korea)
- MHLW (Japan)
- HAS (Singapore)
- TFDA (Thailand)
Customers
Data Residency
US/EU regions
Data Standards
Deployment Model
Features
- Automated brain MRI segmentation (multiple regions including hippocampus)
- Volume quantification per brain region
- White matter hyperintensity (WMH) quantification
- Lesion quantification (MS-focused features)
- Multi-time-point / longitudinal analysis
- Normative comparison with Asian and Western reference datasets
- Configurable report generation with reference statistics
- Color-coded segmentation overlays (DICOM output)
- Radar-chart atrophy pattern visualization for subtype differentiation
- Fast processing (typical 1–10 minutes per study)
- Pre-populated radiological reporting templates
- Automatic labeling and visualization of segmentable structures
Id
SW0138
Integration Partners
Integrations
- PACS / standard radiology reading environment
Languages Supported
- English
- Korean
- Japanese
- Chinese
- Other Languages as Supported by CE Marking
Last Updated
2025-10-11
License
Commercial
Market Segment
Optional Modules
- AQUA AD (Alzheimer's / anti-amyloid treatment monitoring)
- AQUA for MS (multiple sclerosis lesion analysis)
Os Platforms
Pricing Details
Contact vendor for pricing information.
Pricing Model
Subscription
Privacy Features
- BAA available
- consent mgmt
- anonymization
- data minimization
Product Code
SW0138
Product Name
Neurophet AQUA
Ratings
Regions Available
Related Urls
Release Year
Security Features
- Encryption
- RBAC
- SSO/SAML
- audit logs
- 2FA
- DLP
Specialties
Support Channels
System Requirements
Target Users
- Clinicians
- Radiologists
- Neurologists
- Researchers
- Healthcare Providers
Training Options
Type
product
User Reviews
Version
1.0
Alternatives
See related products
Canonical JSON
{
"product_name": "Neurophet AQUA",
"company_name": "Neurophet",
"product_url": "https://neurophet.com/Products/AQUA",
"company_url": "https://neurophet.com",
"related_urls": [
"https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices"
],
"product_code": "SW0138",
"summary": "Neurophet AQUA is an AI-powered software that analyzes brain MRI scans to assist in diagnosing and monitoring neurodegenerative diseases, including Alzheimer's and multiple sclerosis.",
"description": "Neurophet AQUA utilizes artificial intelligence to analyze brain MRI scans, providing rapid segmentation and analysis of brain images within five minutes. It quantifies brain volume and white matter hyperintensities (WMH), aiding in the diagnosis and prognosis assessment of neurodegenerative diseases such as Alzheimer's and multiple sclerosis. The software offers automated brain segmentation, atrophy pattern analysis by brain region, brain atrophy percentile analysis, and automated inter-operation with PACS. It is FDA-cleared, CE-marked, and approved in multiple countries, including Korea, Japan, and Singapore.",
"categories": [
"clinical Care",
"diagnostic Support",
"imaging Software",
"ai Clinical Documentation Integrity",
"clinical Decision Support",
"chronic Care Management",
"medical Device",
"regulatory Compliance",
"Clinical",
"Diagnostic",
"Medical Imaging",
"Artificial Intelligence",
"Neurodegenerative Diseases",
"Multiple Sclerosis",
"Alzheimer's Disease",
"Medical Device",
"Fda-cleared",
"Ce-marked"
],
"market_segment": [
"Enterprise",
"SMB",
"Consumer"
],
"target_users": [
"Clinicians",
"Radiologists",
"Neurologists",
"Researchers",
"Healthcare Providers"
],
"specialties": [
"Neurology",
"Radiology",
"Neurodegenerative Diseases",
"Multiple Sclerosis",
"Alzheimer's Disease"
],
"regions_available": [
"United States",
"South Korea",
"Japan",
"Singapore",
"European Union",
"Other Countries with CE Marking"
],
"languages_supported": [
"English",
"Korean",
"Japanese",
"Chinese",
"Other Languages as Supported by CE Marking"
],
"pricing_model": "Subscription",
"pricing_details": "Contact vendor for pricing information.",
"license": "Commercial",
"company_offices": [
"South Korea",
"United States",
"Japan",
"Singapore",
"European Union"
],
"company_founding": "2016",
"deployment_model": [
"on_prem"
],
"os_platforms": [
"Windows"
],
"features": [
"Automated brain MRI segmentation (multiple regions including hippocampus)",
"Volume quantification per brain region",
"White matter hyperintensity (WMH) quantification",
"Lesion quantification (MS-focused features)",
"Multi-time-point / longitudinal analysis",
"Normative comparison with Asian and Western reference datasets",
"Configurable report generation with reference statistics",
"Color-coded segmentation overlays (DICOM output)",
"Radar-chart atrophy pattern visualization for subtype differentiation",
"Fast processing (typical 1–10 minutes per study)",
"Pre-populated radiological reporting templates",
"Automatic labeling and visualization of segmentable structures"
],
"optional_modules": [
"AQUA AD (Alzheimer's / anti-amyloid treatment monitoring)",
"AQUA for MS (multiple sclerosis lesion analysis)"
],
"integrations": [
"PACS / standard radiology reading environment"
],
"data_standards": [
"DICOM"
],
"api_available": "unknown",
"system_requirements": "",
"compliance": [
"US FDA 510(k) cleared",
"CE (MDD)",
"MFDS (Korea)",
"MHLW (Japan)",
"HAS (Singapore)",
"TFDA (Thailand)"
],
"certifications": [
"FDA 510(k)",
"CE (MDD)",
"MFDS (Korea)",
"MHLW (Japan)",
"HAS (Singapore)",
"TFDA (Thailand)"
],
"security_features": [
"Encryption",
"RBAC",
"SSO/SAML",
"audit logs",
"2FA",
"DLP"
],
"privacy_features": [
"BAA available",
"consent mgmt",
"anonymization",
"data minimization"
],
"data_residency": "US/EU regions",
"customers": [],
"user_reviews": [],
"ratings": [],
"support_channels": [],
"training_options": [],
"release_year": "",
"integration_partners": [],
"id": "SW0138",
"slug": "neurophet-aqua",
"type": "product",
"version": "1.0",
"last_updated": "2025-10-11",
"links_json": {
"self": "https://www.healthaidb.com/software/neurophet-aqua.json"
}
}